Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome

Hussein F. Sakr, Fahaid H. Al-Hashem, Waffaa M.Hassab El-Naby, Mahmoud A. Alkhatee, Mohamed Samir A. Zaki, Hesham M.El Refaey, Mohamed D. Morsy

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pioglitazone (Pio) and swimming exercise (SE) are insulin sensitisers. This investigation was suggested because of the significant side effects associated with Pio treatment in metabolic syndrome (MetS). This study was, therefore, designed to investigate the preventive role of Pio treatment and SE in terms of efficiency and pathological changes in MetS in a rat model. Sixty male Sprague-Dawley rats were distributed equally among 6 groups: (i) control group (C), (ii) exercised control group (C+E), (iii) Pio-treated control group (C+Pio), (iv) group with MetS, (v) group with MetS treated with Pio (MetS+Pio), and (vi) exercised MetS group (MetS+E). Systolic blood pressure and heart rate were measured at the end of the experiments (16 weeks). Retro-orbital blood samples were used to determine the serum levels of glucose, insulin, lipids, gamma glutamyl transferase, alanine transaminase, aspartate transaminase, alkaline phosphatase, fetuin-A, and adiponectin. Semiquantitative reverse transcriptase - PCR insulin gene expression assays and hepatic histopathological examination were conducted. Swimming exercise significantly improved all of the aforementioned parameters, more so than the Pio treatment. In particular, the serum hepatic enzyme levels and hepatic histopathological changes were improved compared with the MetS group. These results suggested that swimming exercise might be an alternative physiological preventive tool against hepatic dysfunction to avoid the side effects associated with Pio treatment, and this could be demonstrated in a rat model of metabolic syndrome.

Original languageEnglish
Pages (from-to)162-170
Number of pages9
JournalCanadian Journal of Physiology and Pharmacology
Volume92
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

pioglitazone
Liver
Therapeutics
Insulin
Control Groups
alpha-2-HS-Glycoprotein
Blood Pressure
Adiponectin
Transferases
Aspartate Aminotransferases

Keywords

  • Adiponectin
  • Metabolic syndrome
  • Pioglitazone
  • Semiquantitative RT-PCR for insulin gene expression
  • Swimming exercise

ASJC Scopus subject areas

  • Medicine(all)
  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome. / Sakr, Hussein F.; Al-Hashem, Fahaid H.; El-Naby, Waffaa M.Hassab; Alkhatee, Mahmoud A.; Zaki, Mohamed Samir A.; Refaey, Hesham M.El; Morsy, Mohamed D.

In: Canadian Journal of Physiology and Pharmacology, Vol. 92, No. 2, 02.2014, p. 162-170.

Research output: Contribution to journalArticle

Sakr, Hussein F. ; Al-Hashem, Fahaid H. ; El-Naby, Waffaa M.Hassab ; Alkhatee, Mahmoud A. ; Zaki, Mohamed Samir A. ; Refaey, Hesham M.El ; Morsy, Mohamed D. / Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome. In: Canadian Journal of Physiology and Pharmacology. 2014 ; Vol. 92, No. 2. pp. 162-170.
@article{e63bcb9c476d4e1c8292374055a9234a,
title = "Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome",
abstract = "Pioglitazone (Pio) and swimming exercise (SE) are insulin sensitisers. This investigation was suggested because of the significant side effects associated with Pio treatment in metabolic syndrome (MetS). This study was, therefore, designed to investigate the preventive role of Pio treatment and SE in terms of efficiency and pathological changes in MetS in a rat model. Sixty male Sprague-Dawley rats were distributed equally among 6 groups: (i) control group (C), (ii) exercised control group (C+E), (iii) Pio-treated control group (C+Pio), (iv) group with MetS, (v) group with MetS treated with Pio (MetS+Pio), and (vi) exercised MetS group (MetS+E). Systolic blood pressure and heart rate were measured at the end of the experiments (16 weeks). Retro-orbital blood samples were used to determine the serum levels of glucose, insulin, lipids, gamma glutamyl transferase, alanine transaminase, aspartate transaminase, alkaline phosphatase, fetuin-A, and adiponectin. Semiquantitative reverse transcriptase - PCR insulin gene expression assays and hepatic histopathological examination were conducted. Swimming exercise significantly improved all of the aforementioned parameters, more so than the Pio treatment. In particular, the serum hepatic enzyme levels and hepatic histopathological changes were improved compared with the MetS group. These results suggested that swimming exercise might be an alternative physiological preventive tool against hepatic dysfunction to avoid the side effects associated with Pio treatment, and this could be demonstrated in a rat model of metabolic syndrome.",
keywords = "Adiponectin, Metabolic syndrome, Pioglitazone, Semiquantitative RT-PCR for insulin gene expression, Swimming exercise",
author = "Sakr, {Hussein F.} and Al-Hashem, {Fahaid H.} and El-Naby, {Waffaa M.Hassab} and Alkhatee, {Mahmoud A.} and Zaki, {Mohamed Samir A.} and Refaey, {Hesham M.El} and Morsy, {Mohamed D.}",
year = "2014",
month = "2",
doi = "10.1139/cjpp-2013-0043",
language = "English",
volume = "92",
pages = "162--170",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "2",

}

TY - JOUR

T1 - Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome

AU - Sakr, Hussein F.

AU - Al-Hashem, Fahaid H.

AU - El-Naby, Waffaa M.Hassab

AU - Alkhatee, Mahmoud A.

AU - Zaki, Mohamed Samir A.

AU - Refaey, Hesham M.El

AU - Morsy, Mohamed D.

PY - 2014/2

Y1 - 2014/2

N2 - Pioglitazone (Pio) and swimming exercise (SE) are insulin sensitisers. This investigation was suggested because of the significant side effects associated with Pio treatment in metabolic syndrome (MetS). This study was, therefore, designed to investigate the preventive role of Pio treatment and SE in terms of efficiency and pathological changes in MetS in a rat model. Sixty male Sprague-Dawley rats were distributed equally among 6 groups: (i) control group (C), (ii) exercised control group (C+E), (iii) Pio-treated control group (C+Pio), (iv) group with MetS, (v) group with MetS treated with Pio (MetS+Pio), and (vi) exercised MetS group (MetS+E). Systolic blood pressure and heart rate were measured at the end of the experiments (16 weeks). Retro-orbital blood samples were used to determine the serum levels of glucose, insulin, lipids, gamma glutamyl transferase, alanine transaminase, aspartate transaminase, alkaline phosphatase, fetuin-A, and adiponectin. Semiquantitative reverse transcriptase - PCR insulin gene expression assays and hepatic histopathological examination were conducted. Swimming exercise significantly improved all of the aforementioned parameters, more so than the Pio treatment. In particular, the serum hepatic enzyme levels and hepatic histopathological changes were improved compared with the MetS group. These results suggested that swimming exercise might be an alternative physiological preventive tool against hepatic dysfunction to avoid the side effects associated with Pio treatment, and this could be demonstrated in a rat model of metabolic syndrome.

AB - Pioglitazone (Pio) and swimming exercise (SE) are insulin sensitisers. This investigation was suggested because of the significant side effects associated with Pio treatment in metabolic syndrome (MetS). This study was, therefore, designed to investigate the preventive role of Pio treatment and SE in terms of efficiency and pathological changes in MetS in a rat model. Sixty male Sprague-Dawley rats were distributed equally among 6 groups: (i) control group (C), (ii) exercised control group (C+E), (iii) Pio-treated control group (C+Pio), (iv) group with MetS, (v) group with MetS treated with Pio (MetS+Pio), and (vi) exercised MetS group (MetS+E). Systolic blood pressure and heart rate were measured at the end of the experiments (16 weeks). Retro-orbital blood samples were used to determine the serum levels of glucose, insulin, lipids, gamma glutamyl transferase, alanine transaminase, aspartate transaminase, alkaline phosphatase, fetuin-A, and adiponectin. Semiquantitative reverse transcriptase - PCR insulin gene expression assays and hepatic histopathological examination were conducted. Swimming exercise significantly improved all of the aforementioned parameters, more so than the Pio treatment. In particular, the serum hepatic enzyme levels and hepatic histopathological changes were improved compared with the MetS group. These results suggested that swimming exercise might be an alternative physiological preventive tool against hepatic dysfunction to avoid the side effects associated with Pio treatment, and this could be demonstrated in a rat model of metabolic syndrome.

KW - Adiponectin

KW - Metabolic syndrome

KW - Pioglitazone

KW - Semiquantitative RT-PCR for insulin gene expression

KW - Swimming exercise

UR - http://www.scopus.com/inward/record.url?scp=84893582653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893582653&partnerID=8YFLogxK

U2 - 10.1139/cjpp-2013-0043

DO - 10.1139/cjpp-2013-0043

M3 - Article

VL - 92

SP - 162

EP - 170

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 2

ER -